# Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

> **NCT01758146** · PHASE3 · UNKNOWN · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 412 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Tamoxifen
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT01758146
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2020-01
- **Final completion:** 2020-06
- **Target enrollment:** 412 (ESTIMATED)
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01758146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01758146, "Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01758146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*